Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus Genotype 1”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00720434
What this trial is testing

A Dose Ranging Study Of PF-00868554 In Combination With PEGASYS And COPEGUS In Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C
Pfizer 35
Not applicableStudy completedNCT02629172
What this trial is testing

Drug Use-results Survey in Patients Infected With Hepatitis C Virus Genotype 1

Who this might be right for
Chronic Hepatitis C Virus
AbbVie 3,043
Not applicableStudy completedNCT01750216
What this trial is testing

An Observational Study of Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) on Predictive Values of RVR on Sustained Virological Response in Different Stages of Liver Fibrosis in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 196
Testing effectiveness (Phase 2)Study completedNCT02378935
What this trial is testing

Safety and Efficacy of Voxilaprevir Plus Sofosbuvir/Velpatasvir Fixed Dose Combination in Adults With Chronic Genotype 1 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 205
Early research (Phase 1)Study completedNCT01185860
What this trial is testing

Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 59
Testing effectiveness (Phase 2)Study completedNCT01726517
What this trial is testing

Safety and Efficacy of LDV/SOF Fixed-Dose Combination (FDC) ± Ribavirin in HCV Genotype 1 Subjects

Who this might be right for
Chronic Hepatitis C Virus
Gilead Sciences 100
Early research (Phase 1)Study completedNCT00529321
What this trial is testing

Immunotherapy With TG4040 in Treatment-naïve Patients Chronically Infected With Hepatitis C Virus

Who this might be right for
Hepatitis C, Chronic
Transgene 42
Testing effectiveness (Phase 2)Study completedNCT00664625
What this trial is testing

A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 24
Post-approval studies (Phase 4)UnknownNCT02950870
What this trial is testing

Efficacy Study to Evaluate the Effect of New Antiviral Drugs on HCV Infection.

Who this might be right for
Chronic Hepatitis, C Virus
University of Modena and Reggio Emilia 75
Testing effectiveness (Phase 2)Study completedNCT02765490
What this trial is testing

Efficacy and Safety of Combinations of AL-335, Odalasvir (ODV) and Simeprevir (SMV) in the Treatment of Chronic Hepatitis C Infection

Who this might be right for
Hepatitis C, Chronic
Janssen Research & Development, LLC 365
Large-scale testing (Phase 3)Study completedNCT01399619
What this trial is testing

Phase III Trial of BI 201335 (Faldaprevir) in Treatment Naive (TN) and Relapser Hepatitis C Virus (HCV)-Human Immunodeficiency Virus (HIV) Coinfected Patients (STARTverso 4)

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 310
Not applicableStudy completedNCT01641094
What this trial is testing

Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms

Who this might be right for
Chronic Hepatitis C
Foundation for Liver Research 20
Early research (Phase 1)Study completedNCT01081158
What this trial is testing

Safety, Tolerability, PK and PD of SCH 900518 in Naive or Treatment-Experienced Subjects Infected With HCV Genotype 1 (Protocol No. P04695)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 41
Large-scale testing (Phase 3)Study completedNCT00758043
What this trial is testing

A Study Evaluating 24-Week and 48-Week Telaprevir-Based Regimen in Treatment Naïve Subjects With Genotype 1 Chronic Hepatitis C Who Achieve an Extended Rapid Viral Response

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 540
Post-approval studies (Phase 4)Ended earlyNCT02940691
What this trial is testing

Scale-up of Treatment of Hepatitis C Infection Among People Who Inject Drugs

Who this might be right for
Hepatitis C
Kirby Institute 32
Not applicableWithdrawnNCT00571714
What this trial is testing

Pilot Comparison of Standard Antiviral Therapy With and Without 12 Weeks of Betaine in Genotype 1 Naive Patients

Who this might be right for
Chronic Hepatitis C
University of Nebraska
Post-approval studies (Phase 4)Ended earlyNCT00255008
What this trial is testing

Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 121
Testing effectiveness (Phase 2)UnknownNCT00332176
What this trial is testing

Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
BioWest Therapeutics Inc 50
Testing effectiveness (Phase 2)UnknownNCT01272310
What this trial is testing

Clinical Trial to Assess Safety and Efficacy of Combination Therapy: Hydroxychloroquine, Pegylated Interferon Alpha-2a and Ribavirin in Chronic Hepatitis C Subjects Non-responders to the Standard of Care Therapy.

Who this might be right for
Chronic Hepatitis C
Sheba Medical Center 36
Testing effectiveness (Phase 2)Study completedNCT00157534
What this trial is testing

Evaluate the Safety and Efficacy of Celgosivir in Patients With Chronic Hepatitis C Genotype 1 Infection

Who this might be right for
Hepatitis C, Chronic
BioWest Therapeutics Inc 43
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation